{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "currency": "USD", "firstTradeDateMilliseconds": 1627651800000, "priceHint": 2, "exchange": "NGM", "shortName": "Immuneering Corporation", "longName": "Immuneering Corporation", "messageBoardId": "finmb_308350677", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 2.5706916, "regularMarketPrice": 7.98, "marketState": "PRE", "tradeable": false, "cryptoTradeable": false, "regularMarketChange": 0.19999981, "regularMarketTime": 1684180804, "regularMarketDayHigh": 8.49, "regularMarketDayRange": "7.83 - 8.49", "regularMarketDayLow": 7.83, "regularMarketVolume": 67778, "regularMarketPreviousClose": 7.78, "bid": 0.0, "ask": 0.0, "bidSize": 9, "askSize": 8, "fullExchangeName": "NasdaqGM", "financialCurrency": "USD", "regularMarketOpen": 7.92, "averageDailyVolume3Month": 63695, "averageDailyVolume10Day": 75040, "fiftyTwoWeekLowChange": 4.2799997, "fiftyTwoWeekLowChangePercent": 1.1567566, "fiftyTwoWeekRange": "3.7 - 16.167", "fiftyTwoWeekHighChange": -8.187, "fiftyTwoWeekHighChangePercent": -0.50640196, "fiftyTwoWeekLow": 3.7, "fiftyTwoWeekHigh": 16.167, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -2.09, "epsForward": -2.03, "epsCurrentYear": -2.15, "priceEpsCurrentYear": -3.7116277, "sharesOutstanding": 29248700, "bookValue": 4.158, "fiftyDayAverage": 9.4265, "fiftyDayAverageChange": -1.4465003, "fiftyDayAverageChangePercent": -0.1534504, "twoHundredDayAverage": 7.965575, "twoHundredDayAverageChange": 0.014424801, "twoHundredDayAverageChangePercent": 0.0018108926, "marketCap": 233404624, "forwardPE": -3.9310346, "priceToBook": 1.919192, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-07-30", "averageAnalystRating": "1.7 - Buy", "displayName": "Immuneering", "symbol": "IMRX"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "245 Main Street", "address2": "Second Floor", "city": "Cambridge", "state": "MA", "zip": "02142", "country": "United States", "phone": "617 500 8080", "website": "https://immuneering.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Immuneering Corporation, a clinical-stage oncology company, engages in the development of medicines for broad populations of cancer patients. Its lead product candidates include IMM-1-104, a dual-MEK inhibitor currently under Phase 1/2a clinical trial to treat patients with cancer, including pancreatic, melanoma, colorectal, and non-small cell lung cancer caused by mutations of RAS and/or RAF; and IMM-6-415 currently in Investigational New Drug application to treat solid tumors. Immuneering Corporation was incorporated in 2008 and is based in Cambridge, Massachusetts.", "fullTimeEmployees": 73, "companyOfficers": [{"maxAge": 1, "name": "Dr. Benjamin J. Zeskind M.B.A., MBA, Ph.D.", "age": 39, "title": "Co-Founder, Pres, CEO & Director", "yearBorn": 1983, "fiscalYear": 2022, "totalPay": {"raw": 898416, "fmt": "898.42k", "longFmt": "898,416"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 374440, "fmt": "374.44k", "longFmt": "374,440"}}, {"maxAge": 1, "name": "Dr. Brett M. Hall Ph.D.", "age": 54, "title": "Chief Scientific Officer", "yearBorn": 1968, "fiscalYear": 2022, "totalPay": {"raw": 867917, "fmt": "867.92k", "longFmt": "867,917"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 453376, "fmt": "453.38k", "longFmt": "453,376"}}, {"maxAge": 1, "name": "Dr. Scott  Barrett M.D.", "age": 59, "title": "Chief Medical Officer", "yearBorn": 1963, "fiscalYear": 2022, "totalPay": {"raw": 656780, "fmt": "656.78k", "longFmt": "656,780"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 276206, "fmt": "276.21k", "longFmt": "276,206"}}, {"maxAge": 1, "name": "Ms. Mallory  Morales CPA", "age": 39, "title": "VP of Fin., Principal Financial & Accounting Officer and Treasurer", "yearBorn": 1983, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Paula  George CPA", "title": "Director of Accounting & Operations and Assistant Corp. Controller", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Michael D. Bookman J.D.", "age": 34, "title": "Chief Legal Officer & Sec.", "yearBorn": 1988, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Leah R. Neufeld", "age": 50, "title": "Chief People Officer", "yearBorn": 1972, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Peter  King Ph.D.", "title": "Head of Discovery & VP", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Praveen  Nair Ph.D.", "title": "Head of Translational Pharmacology & VP", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Harold E. Brakewood", "age": 57, "title": "Chief Bus. Officer", "yearBorn": 1965, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}